Case Overview
When assessing the pathogenic mechanisms of genetic disorders like Autosomal Dominant Polycystic Kidney Disease (ADPKD), an "exclusionary" prediction from a bioinformatics tool can be just as valuable as a positive one. In a study involving two Chinese ADPKD families, the RDDC RNA Splicing Prediction Model (RNA Splicer) AI tool played this critical role. The tool accurately predicted that two novel PKD1 missense variants were not likely to cause disease by affecting splicing, successfully guiding the research team to focus on protein structure alterations and efficiently elucidate the pathogenic mechanism.
Research Challenge: WES Identifies Missense VUS
The study conducted Whole Exome Sequencing (WES) on two ADPKD pedigrees, identifying two novel heterozygous missense variants in exon 29 of the PKD1 gene: c.9857T>C (p.L3286P) in Family 1 and c.9860T>G (p.L3287R) in Family 2.
Neither variant was recorded in gnomAD, and the sites were highly conserved across 15 species, suggesting functional importance. However, missense variants can occasionally disrupt splicing by interfering with elements like Exonic Splicing Enhancers (ESEs). Therefore, before proceeding with complex protein function experiments, it was essential to determine if the pathogenicity operated via the splicing pathway.
RDDC's "Rule-Out" Contribution: Excluding Splicing Aberrations
To quickly assess this possibility, the research team utilized the RDDC RNA Splicing Prediction Model bioinformatics AI tool for an in silico analysis of both missense variants.
RDDC's prediction was clear and definitive: neither the c.9857T>C nor the c.9860T>G variant was likely to significantly impact the mRNA splicing process.
Case Value: RDDC Helps Clarify Pathogenic Pathway, Improving Efficiency
This "negative" prediction from RDDC was extremely valuable. It allowed the research team to confidently rule out aberrant splicing as the pathogenic pathway, thereby saving the time and resources that would have been spent on unnecessary minigene assays or other splicing experiments. The team was able to focus their efforts entirely on the protein level.
Subsequent SWISS-MODEL protein modeling confirmed that both missense variants indeed altered the hydrogen bond network within a critical α-helix of the PC-1 protein (encoded by PKD1), disrupting its conformational stability. This was identified as the pathogenic mechanism, likely interfering with the PC-1/PC-2 complex and leading to cyst formation.
This case clearly demonstrates that RDDC RNA Splicer is not only a powerful tool for identifying splicing errors but also an essential component in the bioinformatics pipeline for ruling them out. This exclusionary function helps researchers streamline their investigation, focus on the correct pathogenic pathway, and significantly accelerate the pace of mechanistic discovery in rare diseases.
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article:
Wang Y, Jin J, Chai Y, et al. Genetic analysis and counseling of ADPKD caused by novel heterozygous mutations of PKD1 in two Chinese families: Case report. Frontiers in Pediatrics. 2024 Feb 9;12:1341063.
Article Link:
https://pubmed.ncbi.nlm.nih.gov/39634429/
